JAPhA’s impact as a journal grows significantly
Pharmacists’ research is spreading to wider audiences, according to new data. JAPhA’s impact factor, a measure of the importance of a journal based on article citations, has increased substantially. JAPhA is APhA’s peer-reviewed journal and includes research on medication use and health outcomes, health care policy, and pharmacist-provided services.
JAPhA’s Journal Impact Factor, a journal-level metric calculated from data indexed in the Web of Science Core Collection, increased to 2.5 compared with less than 1.5 in 2017.
In 2023, JAPhA articles were cited by other journals 4,062 times, according to Journal Citation Reports. In 2017, by comparison, JAPhA articles were cited 2,031 times.
The top 5 cited research articles published in JAPhA in 2021 and 2022 are:
- Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis, lead author Lucas A. Berenbrok, PharmD, MS, of the University of Pittsburgh
- The impact of the COVID-19 pandemic on medical conditions and medication adherence in with chronic diseases, lead author Rima A. Mohammad, PharmD, BCPS FCCP, of the University of Michigan
- Essential services: Quantifying the contributions of America's pharmacists in COVID-19 clinical interventions, lead author John D. Grabenstein, RPh, PhD, FAPhA, FASHP, of Immunize.org
- Expanded roles of community pharmacists in COVID-19: A scoping literature review, lead author Tanapong Pantasri, PharmD, RPh, BCMTMS, AAHIVP, of Organization Las Americas Pharmacy
- COVID-19 and influenza vaccine hesitancy among college students, lead author Jeffrey Bratberg, PharmD, FAPhA, of the University of Rhode Island